TIAM2S阳性微质细胞通过可溶性ICAM-1-介导的免疫原始化增强炎症和神经毒性
Chun-Hsien Chu1,2, Jia-Shing Chen3, Ya-Ling Chan4
1Institute of Molecular Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
概括
微质中的TIAM2S蛋白驱动大脑炎症和神经元损伤. 这种亚群通过可溶性细胞间粘附分子-1增强神经炎症和神经毒性,导致大脑损伤.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- TIAM Rac1相关的GEF 2简称 (TIAM2S) 是一种影响外围免疫细胞的瘤蛋白.
- 目前尚不清楚TIAM2S在微质激活和脑神经炎症中的作用.
研究的目的:
- 研究TIAM2S影响微质免疫性能的机制.
- 确定TIAM2S在塑造微质免疫启动和促进神经元损伤中的作用.
主要方法:
- 在HMC3细胞和人类大脑样本中,西斑和双重免疫染色.
- TIAM2S转基因小鼠和初级神经元质共同培养系统.
- 细胞因子阵列分析和功能增益/丧失实验.
主要成果:
- 在HMC3细胞和人类微质的一个子集 (TIAM2S阳性微质) 中检测到TIAM2S蛋白.
- 在体外和体内,TIAM2S阳性微质促进了LPS诱导的神经炎症和神经损伤.
- 溶性细胞间粘附分子-1 (sICAM-1) 被确定为TIAM2S+微质诱导的神经毒性免疫原始化的调解者.
结论:
- 一个新型的TIAM2S阳性微质子群有助于神经炎症和神经毒性.
- 通过sICAM-1-介导的免疫原始化,TIAM2S阳性微质会增强大脑炎症和神经元损伤.
更多相关视频
09:12Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
Published on: January 30, 2014
16.0K
10:40Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain
Published on: October 27, 2019
32.3K
相关概念视频
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
